reference/20099394

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20099394

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	211
issn	1387-2877 1875-8908
issueIdentifier	1
pageRange	203-211
publicationName	Journal of Alzheimer's disease : JAD
startingPage	203
bibliographicCitation	Angelucci F, Bernardini S, Gravina P, Bellincampi L, Trequattrini A, Di Iulio F, Vanni D, Federici G, Caltagirone C, Bossù P, Spalletta G. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study. J Alzheimers Dis. 2009;17(1):203–11. doi: 10.3233/jad-2009-1031. PMID: 19494443.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d814f5c4c264864f8d2a9858c3192fc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_386b65cd873a5a9c74d72c53549e332b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f423cc9b14bb3dc37e32b0440748f6a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_087806634bf8ee71fa06d66bd891c739 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_777a425766e462c1e101fb0197c824f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_851b6e2ea8aa276326315a68caef1559 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_563b342e6a20d02538abc0317942c0a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6ec3eb99c572368d6ea37426b0f4f46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4e424076834e260afcf7a49828b6b18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a97e5867cbe4c7b8ea81fddf083e8c8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebe3b65e868d8c673987ecc73f6f400e
date	2009-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19494443 https://doi.org/10.3233/jad-2009-1031
isPartOf	https://portal.issn.org/resource/ISSN/1387-2877 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1875-8908
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Delusion Symptoms and Response to Antipsychotic Treatment are Associated with the 5-HT2A Receptor Polymorphism (102T/C) in Alzheimer's Disease: A 3-Year Follow-up Longitudinal Study
discusses	http://id.nlm.nih.gov/mesh/M0237044 http://id.nlm.nih.gov/mesh/M0021770
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D044402Q000235 http://id.nlm.nih.gov/mesh/D011110Q000235 http://id.nlm.nih.gov/mesh/D014150Q000627 http://id.nlm.nih.gov/mesh/D000544Q000188 http://id.nlm.nih.gov/mesh/D000544Q000235 http://id.nlm.nih.gov/mesh/D000544Q000150 http://id.nlm.nih.gov/mesh/D003702Q000209 http://id.nlm.nih.gov/mesh/D010597
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D016009 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000704 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011569 http://id.nlm.nih.gov/mesh/D008137
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9c095a2dc3da1cc8afd181ebab4479b2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7893 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9013 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fc1f575a5ce359bf60d6c6d227334ed5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128442098 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3356 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897

Total number of triples: 65.